Apr 17, 2020
MedTest Dx Manufactures the Only FDA Approved Quantitative Test for G6PD, Critical when Considering COVID-19 Treatment with Chloroquine and Hydroxychloroquine
Mar 24, 2020
Prestigious Specialty Medical Event Is Canceled Due to Coronavirus Concerns: Dozens of the Nation's Top Doctors on Healing Disease Through the Gut's Microbiome Were Set to Meet for the Malibu Microbiome Meeting on March 28-29, 2020 in Malibu, California
Jun 19, 2019
Pompe disease Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Feb 18, 2019
QOL Medical, LLC Unveils Its First Sucrose (sugar) Intolerance Disease Awareness Ad Campaign Titled "All Movies End with a Flush" to Tie in with Movie Award Season
Dec 28, 2018
Aerodiagnostics Welcomes Dr. Kathleen O'Neil-Smith as Medical Director
Oct 15, 2018
Applied Therapeutics to Present New Data on Novel Investigational Treatment for Galactosemia at 2018 NORD Summit
Oct 08, 2018
Viking Therapeutics Announces Data from In Vivo Study of VK2809 Presented at Oral Plenary Session of the 88th Annual Meeting of American Thyroid Association (ATA)
Sep 24, 2018
Audentes Therapeutics to Present New Data from ASPIRO, the Phase 1/2 Clinical Trial of AT132 in Patients with X-Linked Myotubular Myopathy, at the 23rd International Congress of the World Muscle Society
Aug 15, 2018
Perlara announces Glycogen Storage Diseases PerlQuest with the University of Notre Dame
Jul 11, 2018
Applied Therapeutics to Present New Data on Prevention and Treatment of Galactosemia Complications at the Galactosemia Foundation Conference
Apr 02, 2018
Sugar May Be To Blame For Those Who Suffer From Painful Digestion Symptoms Like Abdominal Pain, Bloating, Gas, and Diarrhea.
Feb 22, 2018
Applied Therapeutics Announces Support for Rare Disease Day 2018
Feb 06, 2018
Audentes Therapeutics Announces Selection of Optimized Clinical Development Candidate for Pompe Disease Program
Feb 05, 2018
Valerion to Present Initial Clinical Data with VAL-1221 in Pompe Disease
Sep 07, 2017
Viking Therapeutics Announces Presentation of Data from In Vivo Proof-of-Concept Study of VK2809 in Glycogen Storage Disease Ia (GSD Ia) at the 13th International Congress of Inborn Errors of Metabolism (ICIEM)